Dr. Reddys Laboratories Ltd.

United States Food & Drug Administration (USFDA) has completed a routine cGMP inspection at Dr. Reddy's Laboratories’ formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad. The inspection was conducted from October 19, 2023 to October 27, 2023. USFDA has issued a Form 483 with ten observations. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.